Pfizer (PFE) Tops Q2 EPS by 1c, Updates FY EPS Guidance
Tweet
Share
E-mail
Get Alerts PFE Hot Sheet
Price: $24.90 -0.72%
EPS Growth %: -12.8%
Financial Fact:
Discontinued operations--net of tax: 0
Today's EPS Names:
MAYS, CRMT, REPL, More
EPS Growth %: -12.8%
Financial Fact:
Discontinued operations--net of tax: 0
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
Pfizer (NYSE: PFE) reported Q2 EPS of $0.67, $0.01 better than the analyst estimate of $0.66. Revenue for the quarter came in at $12.9 billion versus the consensus estimate of $13.08 billion.
GUIDANCE:
Pfizer sees FY2017 EPS of $2.54-$2.60, versus the consensus of $2.55. Pfizer sees FY2017 revenue of $52-54 billion.
For earnings history and earnings-related data on Pfizer (PFE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
- Pfizer reaffirms 2026 guidance after CFO transition news
- Pfizer executive says China now leads Europe in drug innovation
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
